Prospects for genetic intervention in primary open-angle glaucoma

Drugs and Aging

Volumn 13, Issue 5, 1998, Pages 333-340

  Wirtz, Mary K ^a,b   Acott, Ted S ^a,b   Samples, John R ^a   Morrison, John C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL GLAUCOMA; DISEASE CLASSIFICATION; GENE THERAPY; GENOTYPE; HUMAN; MOLECULAR GENETICS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; REVIEW;

EID: 0031726381     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199813050-00001     Document Type: Review

References (42)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93
2. Shields MB, Ritch R, Krupin T. Classification of the glaucomas. In: Shields MB, Ritch R, Krupin T, editors. The glaucomas. 2nd ed. St Louis: Mosby-Year Book Inc., 1996: 717-25
3. Quigley HA. Open-angle glaucoma. N Engl J Med 1993; 328: 1097-106
4. Wilson MR, Martone JF. Epidemiology of chronic open-angle glaucoma. In: Ritch R, Shields MB, Krupin T, editors. The glaucomas. 2nd ed. St Louis: Mosby-Year Book Inc., 1996: 753-68
5. Ritch R, Shields MB, Krupin T. Chronic open-angle glaucoma: treatment overview. In: Ritch R, Shields MB, Krupin T, editors. The glaucomas. 2nd ed. St Louis: Mosby-Year Book Inc., 1996: 1507-19
6. Sheffield VC, Stone EM, Alward WLM, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet 1993; 4: 47-50
7. Richards JE, Lichter PR, Boehnke M, et al. Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome 1q. Am J Hum Genet 1994; 54: 62-70
8. Morissette J, Côté G, Anctil J-L, et al. A common gene for juvenile and adult-onset primary open-angle glaucomas confined on chromosome 1q. Am J Hum Genet 1995; 56: 1431-42
9. Wiggs JL, Haines JL, Paglinauan C, et al. Genetic linkage of autosomal dominant juvenile glaucoma to 1q21-q31 in three affected pedigrees. Genomics 1994; 21: 299-303
10. Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 1997; 211: 126-39
11. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275: 668-70
12. Adam MF, Belmouden A, Binisti P, et al. Recurrent mutations in a single exon encoding the evolutionary conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 1997; 6: 2091-7
13. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. Invest Ophthalmol Vis Sci 1965; 4: 187-97
14. Kubota R, Noda S, Wang Y, et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics 1997; 41: 360-9
15. Stoilova D, Child A, Trifan OC, et al. Localisation of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region. Genomics 1996; 36: 142-50
16. Wirtz MK, Samples JR, Kramer PL, et al. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet 1997; 60: 296-304
17. Trifan OC, Traboulsi EI, Stoilova D, et al. The third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region. Am J Opthalmol 1998; 126: 17-28
18. Sarfarazi M, Child A, Stoilova D, et al. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet 1998; 62: 641-52
19. Wirtz MK, Samples JR, Rust K, et al. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36. Arch Opthalmol. In press
20. Andersen JS, Pralea AM, DelBono EA, et al. A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol 1997; 115: 384-8
21. Sarfarazi M. Recent advances in molecular genetics of glaucomas. Hum Mol Genet 1997; 6: 1667-77
22. Sarfarazi M, Akarsu AN, Hossain A, et al. Assignment of a locus (GLC3A) for primary congenital glaucoma (buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 1995; 30: 171-7
23. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997; 6: 641-8
24. Akarsu AN, Turacli ME, Aktan SG, et al. A second locus (GLC3B) for primary congenital glaucoma (buphthalmos) maps to the 1p36 region. Hum Mol Genet 1996; 5: 1199-203
25. Johnson AT, Alward WLM, Sheffield VC, et al. Genetics and glaucoma. In: Ritch R, Shields MB, Krupin T, editors. The glaucomas. 2nd ed. St Louis: Moshy-Year Book Inc., 1996: 39-54
26. Meyer A, Béchetoille A, Valtot F, et al. Age-dependent penetrance and mapping of the locus for juvenile and early-onset open-angle glaucoma on chromosome 1q (GLC1A) in a French family. Hum Genet 1996; 98: 567-71
27. Wax M, Patil R. A rationale for gene targeting in glaucoma therapy. J Ocul Pharmacol 1994; 10: 403-10
28. Borrás T, Tamm ER, Zigler JS Jr. Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthalmol Vis Sci 1996; 37: 1282-93
29. Budenz DL, Bennett J, Alonso L, et al. In vivo gene transfer into murine corneal enduthelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci 1995; 36: 2211-5
30. Buckel P. Recombinant proteins for therapy. Trends Prot Sci 1996; 17: 450-6
31. Parshley DE, Bradley JM, Samples JR, et al. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 1995; 14: 537-44
32. Weatherall DJ. Scope and limitations of gene therapy. Br Med Bull 1995; 51: 1-11
33. Bennett J, Tanabe T, Sun D, et al. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med 1996; 2: 649-54
34. Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke 1996; 27: 1688-93
35. Acott TS, Samples JR, Bradley JMB, et al. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol 1989; 107: 1-6
36. 3H-thymidine labelling; an autoradiographic study in cats. Curr Eye Res 1992; 11: 297-306
37. Schofield JP, Caskey CT. Non-viral approaches to gene therapy. Br Med Bull 1995; 51: 56-71
38. Rosenfeld MA. Human artificial chromosomes get real. Nat Genet 1997; 15: 333-5
39. Huxley C. Mammalian artificial chromosomes: a new tool for gene therapy. Gene Ther 1994; 1: 7-12
40. Rossi JJ. Therapeutic antisense and ribozymes. Br Med Bull 1995; 51: 217-25
41. Jones JT, Lee S-W, Sullenger BA. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat Med 1996; 2: 643-8
42. Gewirtz AM, Stein CA, Glaser PM. Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci U S A 1996; 93: 3161-3